南予医学雑誌19巻

44/92

南予医誌　Vol.19　No. １　2019－42－Lipid-lowering therapy in patients undergoing percutaneous coronary interventionAbstract　Reductions in low-density lipoprotein cholesterol （LDL-C） level reduce the frequency of cardiovascular events. The purpose of this study was to investigate lipid-lowering therapy for patients undergoing percutaneous coronary intervention （PCI） in our hospital from April 2015 to March 2017. A total of 239 patients were separated into two groups （emergency or elective PCI）. Oral statins were prescribed significantly less often in the former group than in the latter group at baseline. Therefore, the LDL-C level was significantly higher in the emergency PCI group （121.9 mg/dL vs. 104.0 mg/dL; p<0.01）. The LDL-C levels after PCI were approximately equal in both groups （79.6 mg/dL vs. 80.0 mg/dL; p=0.90）, and were well-controlled.（Nan-yo Med J 2019; 19: 36-42.）Keywords: Percutaneous coronary intervention, lipid-lowering therapy, low-density lipoprotein cholesterolTamami KONO, Akiyoshi OGIMOTO, Yuki YOKOMOTO,Yuta WATANABE, Kiyotaka OHSHIMA, Mareomi HAMADADivision of Cardiology, Uwajima City Hospital1-1 Goten-machi, Uwajima, Ehime 798-8510, Japan９）　 Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med 2015;372:2387-2397.10）　 Teramoto T, Uno K, Miyoshi I, Khan I, Gorcyca K, Sanchez RJ, et al. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescrip-tion patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan. Atherosclerosis 2016;251:248-254.